These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6165742)

  • 1. Pharmacokinetics and bioavailability of hydromorphone following intravenous and oral administration to human subjects.
    Vallner JJ; Stewart JT; Kotzan JA; Kirsten EB; Honigberg IL
    J Clin Pharmacol; 1981 Apr; 21(4):152-6. PubMed ID: 6165742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of hydromorphone after intravenous, peroral and rectal administration to human subjects.
    Parab PV; Ritschel WA; Coyle DE; Gregg RV; Denson DD
    Biopharm Drug Dispos; 1988; 9(2):187-99. PubMed ID: 2453226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absolute bioavailability of hydromorphone after peroral and rectal administration in humans: saliva/plasma ratio and clinical effects.
    Ritschel WA; Parab PV; Denson DD; Coyle DE; Gregg RV
    J Clin Pharmacol; 1987 Sep; 27(9):647-53. PubMed ID: 2445789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and bioavailability of hydromorphone: effect of various routes of administration.
    Chang SF; Moore L; Chien YW
    Pharm Res; 1988 Nov; 5(11):718-21. PubMed ID: 2470073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of hydromorphone hydrochloride after intravenous and intramuscular administration of a single dose to American kestrels (Falco sparverius).
    Guzman DS; KuKanich B; Drazenovich TL; Olsen GH; Paul-Murphy JR
    Am J Vet Res; 2014 Jun; 75(6):527-31. PubMed ID: 24866507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of hydromorphone after intravenous and intramuscular administration in male rhesus macaques (Macaca mulatta).
    Kelly KR; Pypendop BH; Christe KL
    J Am Assoc Lab Anim Sci; 2014 Sep; 53(5):512-6. PubMed ID: 25255074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple-dose evaluation of intravenous hydromorphone pharmacokinetics in normal human subjects.
    Hill HF; Coda BA; Tanaka A; Schaffer R
    Anesth Analg; 1991 Mar; 72(3):330-6. PubMed ID: 1704690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Input characteristics and bioavailability after administration of immediate and a new extended-release formulation of hydromorphone in healthy volunteers.
    Drover DR; Angst MS; Valle M; Ramaswamy B; Naidu S; Stanski DR; Verotta D
    Anesthesiology; 2002 Oct; 97(4):827-36. PubMed ID: 12357147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of brotizolam in healthy subjects following intravenous and oral administration.
    Jochemsen R; Wesselman JG; Hermans J; van Boxtel CJ; Breimer DD
    Br J Clin Pharmacol; 1983; 16 Suppl 2(Suppl 2):285S-290S. PubMed ID: 6661374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and oral bioavailability of scopolamine in normal subjects.
    Putcha L; Cintrón NM; Tsui J; Vanderploeg JM; Kramer WG
    Pharm Res; 1989 Jun; 6(6):481-5. PubMed ID: 2762223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of hydrorphone hydrochloride after intravenous and subcutaneous administration in ferrets (Mustela putorius furo).
    Hech B; Knych H; Desprez I; Weiner D; Ambros B
    Vet Anaesth Analg; 2024; 51(2):152-159. PubMed ID: 38158281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and bioavailability of single-dose intranasal hydromorphone hydrochloride in healthy volunteers.
    Coda BA; Rudy AC; Archer SM; Wermeling DP
    Anesth Analg; 2003 Jul; 97(1):117-23, table of contents. PubMed ID: 12818953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and bioavailability of midazolam in man.
    Heizmann P; Eckert M; Ziegler WH
    Br J Clin Pharmacol; 1983; 16 Suppl 1(Suppl 1):43S-49S. PubMed ID: 6138080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacokinetics of intravenous and oral sulpiride in healthy human subjects.
    Wiesel FA; Alfredsson G; Ehrnebo M; Sedvall G
    Eur J Clin Pharmacol; 1980 May; 17(5):385-91. PubMed ID: 7418717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of oral and intravenous omeprazole in patients with the Zollinger-Ellison syndrome.
    Vinayek R; Amantea MA; Maton PN; Frucht H; Gardner JD; Jensen RT
    Gastroenterology; 1991 Jul; 101(1):138-47. PubMed ID: 2044903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and physiological effects of intravenous hydromorphone in conscious dogs.
    Guedes AG; Papich MG; Rude EP; Rider MA
    J Vet Pharmacol Ther; 2008 Aug; 31(4):334-43. PubMed ID: 18638294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and absolute bioavailability of diltiazem in humans.
    Ochs HR; Knüchel M
    Klin Wochenschr; 1984 Apr; 62(7):303-6. PubMed ID: 6727272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of azapropazone following single oral and intravenous doses.
    Breuing KH; Gilfrich HJ; Meinertz T; Jähnchen E
    Arzneimittelforschung; 1979; 29(6):971-2. PubMed ID: 582795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and bioavailability of viqualine, a new antidepressant.
    Fourtillan JB; Bouquet S; Girault J; Lefebvre MA; Maulet C; Courtois P
    Eur J Drug Metab Pharmacokinet; 1985; 10(1):3-10. PubMed ID: 4029218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The absolute oral bioavailability and population-based pharmacokinetic modelling of a novel dipeptidylpeptidase-IV inhibitor, vildagliptin, in healthy volunteers.
    He YL; Sadler BM; Sabo R; Balez S; Wang Y; Campestrini J; Laurent A; Ligueros-Saylan M; Howard D
    Clin Pharmacokinet; 2007; 46(9):787-802. PubMed ID: 17713976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.